Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 828 results for "copd"

Swansea University signs licensing agreement with Glyconics to...

Swansea University has closed on an exclusive licensing agreement with Cardiff, UK-based diagnostics company Glyconics Ltd for the use of their proprietary Infrared Spectroscopy to diagnose chronic obstructive pulmonary disease (COPD) from ... Swansea University, 1 hour ago

195 images for copd

Gympie Times, 22 hours ago
Pharmaceutical Journal, 1 day ago
Cambridge Network, 8 hours ago
Wellington Advertiser, 6 days ago
Med India, 1 week ago
MDLinx, 5 hours ago
MDLinx, 5 hours ago
Interaksyon, 9 hours ago
Hamilton Spectator, 15 hours ago
MedPage Today, 17 hours ago
Med India

Oxygen Therapy May Ease Breathlessness in Mild COPD

Reuters Health Information By Anne Harding December16,2014 NEW YORK (Reuters Health) - Some chronic obstructive pulmonary disease (COPD) patients who are currently not eligible for home oxygen may benefit from oxygen therapy for reducing ...
 Medscape1 day ago Chronic Obstructive Pulmonary Disease (COPD)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014  Individual.com3 days ago Do You Have COPD?  BlackDoctor.org1 week ago COPD, Asthma Treatment Aided By CCDSS  Advance for Respiratory Care & Sleep Medicine1 week ago
[x]  
MedPage Today

Inhaled COPD Therapeutics

]]> DUBLIN , Dec. 11, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/cscdh8/inhaled_copd ) has announced the addition of the " " report to their offering. ...
 Sys-Con Italia6 days ago Hot Topic: Combination Inhalers in COPD  MedPage Today6 days ago Market Research Reports, Inc. (www.marketresearchreports.com): The Global COPD and Asthma Devices Market Would Reach $34.3 Billion by 2020, Find New Report  BusinessWeek1 week ago New Patent for COPD Therapy  Advance for Respiratory Care & Sleep Medicine1 week ago
[x]  
Monthly Prescribing Reference

Emphysema on CT Without COPD Predicts Higher Mortality Risk

People whose lungs displayed signs of emphysema in computed tomography (CT) scans were at greater mortality risk, even those without airflow obstruction or without chronic obstructive pulmonary disease (COPD), according to a population-based study. ...
 Medscape2 days ago Greater Emphysema-Like Lung on CT Linked to Mortality  Monthly Prescribing Reference2 days ago Association Between Emphysema-like Lung on Cardiac Computed Tomography and Mortality in Persons Without Airflow Obstruction A Cohort Study  Annals of Internal Medicine2 days ago

Inhaled COPD Therapeutics

By PR Newswire | 12/12/14 - 11:45 AM EST DUBLIN , Dec. 11, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/cscdh8/inhaled_copd ) has announced the addition of the "Inhaled COPD Therapeutics" report to ...
 TheStreet.com6 days ago

Multiples' COPD service improves...

Multiples' COPD service improves
 Chemist+Druggist1 week ago Multiples' COPD service improves inhaler technique  Chemist+Druggist1 week ago
HomeCare Magazine

A New Way with Oxygen

The AirSep Focus is lightweight and unobtrusive. With the rise of heart disease, lung disease and COPD-related conditions, approximately 1.4 million people are using prescribed oxygen in the U.S. today and the number of new users is rising. Oxygen ...
 HomeCare Magazine6 days ago Stroke replaces diarrhoea as top killer in BD  Financial Express Bangladesh1 hour ago Heart diseases lung diseases stroke are Indias top killers  Hindustan Times11 hours ago Tuberculosis, heart disease top causes of death in India: report  Indian Express13 hours ago

Confronting COPD

CBC News: New Brunswick Sort by: CBC News: New Brunswick at 6:00 New Brunswick - December 11, 2014 Dec 11, 2014 | 30:01CBC TV news and weather from
 CBC6 days ago

SMC recommends GSK's Incruse Ellipta to treat COPD within NHS Scotland

The Scottish Medicines Consortium (SMC) has recommended GlaxoSmithKline's (GSK) Incruse Ellipta 55mcg (umeclidinium) to treat patients with chronic obstructive pulmonary (COPD) within NHS Scotland. The positive advice on Incruse Ellipta allows the ...
 Pharmaceutical Technology1 week ago Scottish Medicines Consortium umeclidinium (Incruse)  FirstWord Pharma1 week ago

Airway anatomy as a risk factor of COPD

Search this site Advanced search An international peer-reviewed journal for health professionals in all aspects of
 British Journal of the Thorax1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less